Pulsating aerosols for the rhinosinusitis treatment – evaluation of an innovative method in a multicentric survey


Background Acute and Chronic Rhinosinusitis (ARS/CRS) have a strong healtheconomic impact. It can be assumed that 10-15% of the US and EU population suffers from CRS. The success of topical drug delivery to the sinuses principally desirable is limited because the paranasal cavities are virtually non-ventilated areas. An innovative inhalation system (PARI… (More)